header image

Safety First

At Octapharma, patient safety is critically important and is never left to chance. Our enviable history and proven track record are a function of a highly rigorous process that begins with our raw material, human plasma. All blood donors, collection centers, and donated blood, are held to the highest standards. Once received in our facility, a highly precise and multi-stage virus inactivation process takes over before releasing finished goods into the marketplace.




Donors themselves must undergo a comprehensive up-front and ongoing review process. Prior to each donation, donors are assigned a unique ID, and registered in the Octapharma donor database. A deferral check is conducted, and a detailed health history is taken. An accredited healthcare professional then provides an overall assessment, and will exclude any donor that does not meet the acceptance criteria.


Plasma Collection Centers


In the US, Octapharma Plasma Donation Centers are routinely inspected and approved by the FDA.


Donated Plasma Screening


Once received from the collection centers, all donated plasma undergoes individual unit testing for antibodies against HIV-1/2, HBV, HCV and syphilis. Plasma also undergoes PCR (NAT) testing for HIV, HBV, HCV and parvovirus B19. The result of this process is an exceptionally pure, high quality fresh frozen plasma (FFP) product.

* The effectiveness of this process to remove prion infectivity has not been established.